光化性角化病的最佳治疗方法。
Optimal treatment of actinic keratoses.
机构信息
Department of Dermatology, Wayne State University School of Medicine, Detroit, MI, USA.
出版信息
Clin Interv Aging. 2013;8:29-35. doi: 10.2147/CIA.S31930. Epub 2013 Jan 14.
Abstract
The most compelling reason and primary goal of treating actinic keratoses is to prevent malignant transformation into invasive squamous cell carcinoma, and although there are well established guidelines outlining treatment modalities and regimens for squamous cell carcinoma, the more commonly encountered precancerous actinic lesions have no such standard. Many options are available with variable success and patient compliance rates. Prevention of these lesions is key, with sun protection being a must in treating aging patients with sun damage as it is never too late to begin protecting the skin.
摘要
治疗光化性角化病最有说服力的原因和主要目标是防止恶性转化为侵袭性鳞状细胞癌，虽然已经有明确的指南概述了鳞状细胞癌的治疗方式和方案，但更常见的癌前光化性病变没有这样的标准。有许多可供选择的方法，成功率和患者依从率各不相同。预防这些病变是关键，对于因日晒而受损的老年患者，防晒是必须的，因为保护皮肤永远不会太晚。
相似文献
1
Optimal treatment of actinic keratoses.
Clin Interv Aging. 2013;8:29-35. doi: 10.2147/CIA.S31930. Epub 2013 Jan 14.
2
[Diagnosis and treatment of actinic keratosis].
Duodecim. 2015;131(9):863-70.
3
[A plethora of choices: treating actinic keratoses].
Rev Med Suisse. 2020 Apr 1;16(688):646-650.
4
Management of patients with actinic keratoses.
Br J Nurs. 2012;21(10):S27-30. doi: 10.12968/bjon.2012.21.Sup10.S27.
5
Therapeutic strategies for actinic keratoses--a systematic review.
Eur J Dermatol. 2013 Jan-Feb;23(1):14-32. doi: 10.1684/ejd.2013.1923.
6
Management of actinic keratosis.
Drug Ther Bull. 2013 Jul;51(7):81-4. doi: 10.1136/dtb.2013.7.0193. Epub 2013 Jul 4.
7
Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Clin Dermatol. 2013 Nov-Dec;31(6):712-7. doi: 10.1016/j.clindermatol.2013.05.007.
8
[Treatment of actinic keratoses in older adults].
Dermatologie (Heidelb). 2023 Sep;74(9):663-669. doi: 10.1007/s00105-023-05208-4. Epub 2023 Aug 18.
9
Current issues in the management of actinic keratosis.
J Am Acad Dermatol. 2013 Jan;68(1 Suppl 1):S28-38. doi: 10.1016/j.jaad.2012.09.051.
10
Current therapies for actinic keratosis.
Int J Dermatol. 2020 Jun;59(6):677-684. doi: 10.1111/ijd.14767. Epub 2020 Feb 3.
引用本文的文献
1
Immunoexpression of Ki67, P16 and Beta-catenin in precursor lesions of cutaneous squamous cell carcinoma.
Rom J Morphol Embryol. 2024 Jan-Mar;65(1):19-25. doi: 10.47162/RJME.65.1.03.
2
Number Bias in Clinicians' Documentation of Actinic Keratosis Removal.
J Clin Med. 2023 Dec 29;13(1):202. doi: 10.3390/jcm13010202.
3
Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review.
Int J Mol Sci. 2023 Mar 5;24(5):4989. doi: 10.3390/ijms24054989.
4
Insurance Coverage of Dermabrasion and Chemical Peel Procedures: A Critical Analysis of 58 American Insurance Companies.
Cureus. 2022 Dec 31;14(12):e33184. doi: 10.7759/cureus.33184. eCollection 2022 Dec.
5
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action.
Clin Cosmet Investig Dermatol. 2022 Nov 16;15:2495-2506. doi: 10.2147/CCID.S374122. eCollection 2022.
6
Profile of Tirbanibulin for the Treatment of Actinic Keratosis.
J Clin Aesthet Dermatol. 2022 Oct;15(10 Suppl 1):S3-S10.
7
[Potassium hydroxide 5 % solution in actinic keratosis : A novel therapeutic approach in the lesion-directed treatment].
Hautarzt. 2021 Nov;72(11):975-983. doi: 10.1007/s00105-021-04888-0. Epub 2021 Aug 13.
8
Guidelines of care for the management of actinic keratosis: Executive summary.
J Am Acad Dermatol. 2021 Oct;85(4):945-955. doi: 10.1016/j.jaad.2021.05.056. Epub 2021 Jun 7.
9
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants.
Adv Drug Deliv Rev. 2021 Aug;175:113803. doi: 10.1016/j.addr.2021.05.013. Epub 2021 May 29.
10
Guidelines of care for the management of actinic keratosis.
J Am Acad Dermatol. 2021 Oct;85(4):e209-e233. doi: 10.1016/j.jaad.2021.02.082. Epub 2021 Apr 2.
本文引用的文献
1
2
Can photodynamic therapy reverse the signs of photoageing and field cancerization?
Br J Dermatol. 2012 Jul;167(1):2. doi: 10.1111/j.1365-2133.2012.10914.x.
3
Treatment-refractory actinic keratoses successfully treated using simultaneous combination topical 5-fluorouracil cream and imiquimod cream: a case-control study.
Dermatol Surg. 2012 Sep;38(9):1469-76. doi: 10.1111/j.1524-4725.2012.02480.x. Epub 2012 Jun 19.
4
Ingenol mebutate gel for actinic keratosis.
N Engl J Med. 2012 Mar 15;366(11):1010-9. doi: 10.1056/NEJMoa1111170.
5
Zyclara (imiquimod) cream, 3.75%.
Skinmed. 2010 Jul-Aug;8(4):227-9.
6
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
J Natl Cancer Inst. 2010 Dec 15;102(24):1835-44. doi: 10.1093/jnci/djq442. Epub 2010 Nov 29.
7
Mechanisms of action of topical 5-fluorouracil: review and implications for the treatment of dermatological disorders.
J Dermatolog Treat. 2012 Apr;23(2):83-9. doi: 10.3109/09546634.2010.507704. Epub 2010 Oct 31.
8
9
Spreading pigmented actinic keratosis: a review.
J Am Acad Dermatol. 2010 Sep;63(3):499-506. doi: 10.1016/j.jaad.2009.07.026. Epub 2010 Mar 23.
10
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles.
J Am Acad Dermatol. 2010 Apr;62(4):582-90. doi: 10.1016/j.jaad.2009.07.004. Epub 2010 Feb 4.
Zotero 插件